TCF20 dysfunction leads to cortical neurogenesis defects and autistic-like behaviors in mice

EMBO Rep. 2020 Aug 5;21(8):e49239. doi: 10.15252/embr.201949239. Epub 2020 Jun 8.

Abstract

Recently, de novo mutations of transcription factor 20 (TCF20) were found in patients with autism by large-scale exome sequencing. However, how TCF20 modulates brain development and whether its dysfunction causes ASD remain unclear. Here, we show that TCF20 deficits impair neurogenesis in mouse. TCF20 deletion significantly reduces the number of neurons, which leads to abnormal brain functions. Furthermore, transcriptome analysis and ChIP-qPCR reveal that the DNA demethylation factor TDG is a downstream target gene of TCF20. As a nonspecific DNA demethylation factor, TDG potentially affects many genes. Combined TDG ChIP-seq and GO analysis of TCF20 RNA-Seq identifies T-cell factor 4 (TCF-4) as a common target. TDG controls the DNA methylation level in the promoter area of TCF-4, affecting TCF-4 expression and modulating neural differentiation. Overexpression of TDG or TCF-4 rescues the deficient neurogenesis of TCF20 knockdown brains. Together, our data reveal that TCF20 is essential for neurogenesis and we suggest that defects in neurogenesis caused by TCF20 loss are associated with ASD.

Keywords: TDG; DNA demethylation; TCF20; autism spectrum disorder; neurogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autistic Disorder* / genetics
  • DNA Methylation
  • Humans
  • Mice
  • Neurogenesis / genetics
  • Promoter Regions, Genetic
  • Transcription Factors / genetics

Substances

  • TCF20 protein, human
  • Transcription Factors

Associated data

  • GEO/GSE135483